Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis

被引:73
|
作者
Weidling, Ian W. [1 ]
Swerdlow, Russell H. [1 ]
机构
[1] Univ Kansas, Med Ctr, Alzheimers Dis Ctr, Kansas City, KS 66205 USA
关键词
Alzheimer's disease; Aggregation; Metabolism; Mitochondria; Proteostasis; Mitophagy; Mitochondrial DNA; MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; CYTOCHROME-C-OXIDASE; DEFICIENT HIPPOCAMPAL-NEURONS; OXIDATIVE DAMAGE; A-BETA; CYTOSOLIC PROTEOSTASIS; ENDOPLASMIC-RETICULUM; ABNORMAL INTERACTION; CASCADE HYPOTHESIS;
D O I
10.1016/j.expneurol.2020.113321
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is a progressive brain disorder characterized by memory loss and the accumulation of two insoluble protein aggregates, tau neurofibrillary tangles and beta-amyloid plaques. Widespread mitochondrial dysfunction also occurs and mitochondria from AD patients display changes in number, ultrastructure, and enzyme activities. Mitochondrial dysfunction in AD presumably links in some way to its other disease characteristics, either as a cause or consequence. This review characterizes AD-associated mitochondrial perturbations and considers their position in its pathologic hierarchy. It focuses on the crosstalk that occurs between mitochondria, nuclear gene expression, and cytosolic signaling pathways that serves to maintain cell homeostasis. To this point, recent evidence indicates mitochondria trigger retrograde responses that influence cell proteostasis in general and AD proteostasis specifically. Potentially pertinent retrograde responses include the mitochondrial unfolded protein response (mtUPR), integrated stress response (ISR), autophagy/mitophagy, and proteasome function. A fuller perspective of mitochondrial dysfunction in AD, and its relation to protein aggregation, could enhance our overall understanding of this disease.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Are mitochondria critical in the pathogenesis of Alzheimer's disease?
    Reddy, PH
    Beal, MF
    BRAIN RESEARCH REVIEWS, 2005, 49 (03) : 618 - 632
  • [42] Brain aging, Alzheimer's disease, and mitochondria
    Swerdlow, Russell H.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (12): : 1630 - 1639
  • [43] Proteostasis failure: at the intersection between aging and Alzheimer's disease
    Poblete, Natalia
    Hetz, Claudio
    NEURAL REGENERATION RESEARCH, 2025, 20 (11) : 3221 - 3222
  • [44] Proteostasis Impairment: At the Intersection between Alzheimer's Disease and Diabetes
    Medinas, Danilo B.
    Hetz, Claudio
    CELL METABOLISM, 2013, 18 (06) : 771 - 772
  • [45] Sweet Mitochondria: A Shortcut to Alzheimer's Disease
    Moreira, Paula I.
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (03) : 1391 - 1401
  • [46] Dysfunction of mitochondria: Implications for Alzheimer's disease
    Albensi, Benedict C.
    MITOCHONDRIAL DYSFUNCTION IN NEURODEGENERATION AND PERIPHERAL NEUROPATHIES, 2019, 145 : 13 - 27
  • [47] Mitochondria and Mitochondrial Cascades in Alzheimer's Disease
    Swerdlow, Russell H.
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (03) : 1403 - 1416
  • [48] Mitochondria as a therapeutic target in Alzheimer's disease
    Wang, Jian
    Chen, Guo-Jun
    GENES & DISEASES, 2016, 3 (03) : 220 - 227
  • [49] Alzheimer's disease: Effects of β-amyloid on mitochondria
    Tillement, Laurent
    Lecanu, Laurent
    Papadopoulos, Vassilios
    MITOCHONDRION, 2011, 11 (01) : 13 - 21
  • [50] Mitochondria, Cybrids, Aging, and Alzheimer's Disease
    Swerdlow, R. H.
    Koppel, S.
    Weidling, I.
    Hayley, C.
    Ji, Y.
    Wilkins, H. M.
    MOLECULAR BIOLOGY OF AGING, 2017, 146 : 259 - 302